Aspira Pathlab & Diagnostics reports standalone net loss of Rs 0.86 crore in the September 2019 quarter
At meeting held on 27 November 2019The Board of Aspira Pathlab & Diagnostics at its meeting held on 27 November 2019 has approved the allotment of 11 lakh equity shares of Rs 10 each for cash at price of Rs 26 per share aggregating Rs 2.86 crore on preferential basis to strategic investors not forming part of promoter group of the company.
Consequent to said allotment, the paid up equity share capital of the Company stand increased from Rs. 8.19 crore to Rs 9.29 crore representing 92,93,000 equity shares of Rs 10 each.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)